Collegium Pharmaceutical Inc (COLL)
Inventory turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 254,105 | 240,598 | 254,445 | 126,251 | 130,180 |
Inventory | US$ in thousands | 35,560 | 32,332 | 46,501 | 17,394 | 15,614 |
Inventory turnover | 7.15 | 7.44 | 5.47 | 7.26 | 8.34 |
December 31, 2024 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $254,105K ÷ $35,560K
= 7.15
The inventory turnover ratio for Collegium Pharmaceutical Inc has shown some fluctuations over the past five years. In December 2020, the ratio stood at 8.34, indicating that the company's inventory turned over approximately 8.34 times during that year. However, by the end of December 2022, the ratio decreased to 5.47, suggesting a decrease in the efficiency of managing inventory.
Subsequently, there was an improvement in the inventory turnover ratio, reaching 7.44 by December 2023 and then slightly decreasing to 7.15 by December 2024. These figures suggest that Collegium Pharmaceutical Inc has been able to better manage its inventory levels and turnover during these years, although there was a slight dip in 2022.
Overall, the trend indicates that the company has been able to maintain a relatively healthy inventory turnover rate, which is essential for managing working capital effectively and optimizing cash flows. Further analysis of industry benchmarks and specific reasons behind the fluctuations in the ratio could provide more insights into the company's inventory management practices.
Peer comparison
Dec 31, 2024